Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common.
5-Year-Old Boy With IQ of 141 Reads 3,000 Books
At five years old, Arjun Vishal Prajapati has explored more than 3,000 books and developed a remarkable interest in science, mathematics and space. His story offers a thoughtful look at nurturing curiosity, supporting gifted learners and making room for a happy, balanced childhood.
0 Comments